ANGO vs T · rev $292.5M vs P/E 7.4, rev $125.65B
AngioDynamics Inc (ANGO) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
ANGO currently screens at market cap $378.5M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the ANGO and T stock pages for the full models.
Not investment advice.